Protagonist Therapeutics (Australia)

Protagonist Therapeutics (Australia) is identified in Wikidata as a company in Brisbane, Australia. The official Protagonist Therapeutics website describes Protagonist as a clinical-stage biopharmaceutical company focused on peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate. The site lists U.S. FDA approvals of MIMRYLO™ (rusfertide) and ICOTYDE™ (icotrokinra), and identifies Dinesh Patel as CEO and Arturo Molina, MD, as Chief Medical Officer.

Protagonist Therapeutics (Australia) is recorded in Wikidata as a company in Brisbane, Australia. The official Protagonist Therapeutics website presents Protagonist as a clinical-stage biopharmaceutical company that seeks to improve patients’ lives through peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate. The site lists U.S. FDA approval of MIMRYLO™ (rusfertide) and U.S. FDA approval of ICOTYDE™ (icotrokinra), and identifies Dinesh Patel as CEO and Arturo Molina, MD, as Chief Medical Officer.

Clinical-stage biopharmaceutical company focused on peptide drug discovery and development for areas of unmet need.

• MIMRYLO™ (rusfertide)

• ICOTYDE™ (icotrokinra)

1. 1Protagonist Therapeutics Inc.protagonist-inc.com
2. 2Events & Presentations - Protagonist Therapeutics Inc.protagonist-inc.com
3. 3Corporate Presentationprotagonist-inc.com
4. 4Protagonist Therapeutics (Australia)wikidata.org
5. 5Protagonist Therapeutics Announces Pricing of $115 Million Upsized Public Offering of Common Stockprnewswire.com
6. 6Protagonist Therapeutics Appoints Scott Plevy, M.D., Executive Vice President and Therapeutic Head, Gastroenterologyprnewswire.com